ENDOTAK RELIANCE® SG 0182Recalls & reported problems
Boston Scientific Corporation · Steroid-Eluting Bipolar Pace/Sense and Defibrillation Lead · Class 3 · Implant
All models of ENDOTAK RELIANCE SG (9)
Data updated Oct 18, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 13
- Deaths reported
- 0
- Injuries reported
- 8
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 13 adverse event reports that list this exact device (DI 00802526531163), received between May 6, 2019 and Jul 29, 2025 — classified as 8 injuries, 5 malfunctions.
The most frequently reported specific device problem is “High impedance” (11 reports).
3 other recalls cover devices cleared under the same FDA submission (P910073); they may or may not involve this specific model.
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Reports received per month
Most reported problems
Device problems
- High impedance11
- Signal Artifact/Noise2
- Adverse Event Without Identified Device or Use Problem1
- Defective Device1
- Device Sensing Problem1
- Failure to Capture1
- Failure to Read Input Signal1
- Fracture1
Patient problems
- No Clinical Signs, Symptoms or Conditions4
- No Known Impact Or Consequence To Patient4
- No Code Available2
- No Consequences Or Impact To Patient2
- Insufficient Information1
- Unspecified Infection1
Recent adverse event reports
The 13 most recent of 13 reports, in the reporter's own words as published by the FDA.
InjuryJul 29, 2025High impedance; High impedance
IT WAS REPORTED THAT UPON REVIEW OF BOSTON SCIENTIFIC LATITUDE REMOTE MONITORING SYSTEM STORED DATA, WE IDENTIFIED EVIDENCE THAT THIS LEAD EXHIBITED HIGH SHOCK IMPEDANCE MEASUREMENTS OF GREATER THAN 125 OHMS. NO ADVERSE PATIENT EFFECTS HAVE BEEN REPORTED. ADDITIONAL INFORMATION WAS RECEIVED THAT THIS RIGHT VENTRICULAR (RV) LEAD WAS SURGICALLY ABANDONED. NO ADDITIONAL ADVERSE PATIENT EFFECTS WERE REPORTED.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 22649183 ↗InjuryNov 15, 2023High impedance; High impedance
IT WAS REPORTED THAT, DURING THE EXPLANT PROCEDURE OF THE OLD DEVICE DUE TO NORMAL BATTERY DEPLETION (NBD), THIS RIGHT VENTRICULAR (RV) LEAD WAS PLUGGED INTO THE NEW DEVICE AND EXHIBITED HIGH SHOCK IMPEDANCES OUT OF RANGE. THE TECHNICAL SERVICES (TS) INDICATED TO THE FIELD REPRESENTATIVE TO UNPLUG ALL ELECTROMAGNETIC INTERFERENCE (EMI) SOURCES, BUT THE MEASUREMENTS WERE STILL OUT OF RANGE. SUBSEQUENTLY, THE RV LEAD WAS SURGICALLY ABANDONED AND REPLACED. NO ADDITIONAL ADVERSE PATIENT EFFECTS WERE REPORTED.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 18144731 ↗InjuryDec 20, 2021High impedance; High impedance
IT WAS REPORTED THAT THIS RIGHT VENTRICULAR (RV) LEAD EXHIBITED HIGH OUT-OF-RANGE SHOCK IMPEDANCE MEASUREMENTS, GREATER THAN 125 OHMS. SUBSEQUENTLY, THE PATIENT UNDERWENT A REVISION PROCEDURE, AND THIS RV LEAD WAS SURGICALLY CAPPED/ABANDONED AND REPLACED WITH A NEW LEAD. IT WAS NOTED THAT THE DEVICE POCKET WAS ALSO REVISED. BESIDES INTERVENTION, THERE WERE NO OTHER ADVERSE PATIENT EFFECTS REPORTED.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 13048414 ↗MalfunctionOct 17, 2021High impedance; High impedance
IT WAS REPORTED THAT THIS PATIENT'S IMPLANTABLE CARDIOVERTER DEFIBRILLATOR STARTED EMITTING BEEPING TONES. TECHNICAL SERVICES (TS) REVIEWED THIS DEVICE DATA AND NOTICED HIGH OUT-OF-RANGE (OOR) SHOCK IMPEDANCE OF 125 OHMS. THE BEEPING WAS CONFIRMED TO HAVE BEEN TRIGGERED BY THE IMPEDANCE MEASUREMENT. THE SHOCK IMPEDANCE TRENDING APPEARS TO BE SLIGHTLY ELEVATED OVER THE LAST YEAR. AS 125 OHMS IS NOT INDICATIVE OF A LEAD FRACTURE, TS RECOMMENDED TO BRING THE PATIENT INTO CLINIC TO TURN BEEPING OFF, EVALUATE THE SHOCK LEAD, INCREASE THE OOR ALERT TO 150 OHMS AND CONTINUE MONITORING THE PATIENT. IF IMPEDANCE EXCEEDS 150 OHMS A COMMANDED SHOCK SHOULD BE CONSIDERED. FURTHER INFORMATION WAS RECEIVED INDICATING THAT NO COMMANDED SHOCKS WERE PERFORMED, AND THE PATIENT WILL CONTINUE TO BE MONITORED. THIS LEAD REMAINS IN SERVICE AND NO ADVERSE PATIENT EFFECTS WERE REPORTED.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 12644221 ↗InjuryJul 23, 2021Signal Artifact/Noise; High impedance; Defective Device; Signal Artifact/Noise; High impedance; Defective Device
IT WAS REPORTED THAT THIS LEAD EXHIBITED HIGH OUT OF RANGE SHOCK IMPEDANCE MEASUREMENTS. BOSTON SCIENTIFIC TECHNICAL SERVICES (TS) REVIEWED THE DATA AND A POSSIBLE LEAD DAMAGE IS SUSPECTED TO BE THE CAUSE OF THE IMPEDANCE ISSUES AND THE NOISY SIGNALS. TROUBLESHOOTING WAS RECOMMENDED BY TS. AT THIS TIME, THE SYSTEM REMAINS IN SERVICE. NO ADVERSE PATIENT EFFECTS WERE REPORTED. ADDITIONAL INFORMATION CONFIRMED THIS PATIENT WILL HAVE A HIGH-ENERGY SHOCK TESTING SCHEDULE. PHYSICIAN IS AWARE OF THE RECOMMENDATION FROM TS.
Patient problems: Insufficient Information
MAUDE report 12221277 ↗MalfunctionJan 2, 2021High impedance; High impedance
IT WAS REPORTED THAT THIS CARDIAC RESYNCHRONIZATION THERAPY DEFIBRILLATOR (CRT-D) DEVICE AND RIGHT VENTRICULAR (RV) LEAD, EXHIBITED HIGH OUT OF RANGE SHOCK IMPEDANCE OF 127 OHMS. THE PHYSICIAN ADVISED THEY BELIEVE IT MAY BE DUE TO A RECENT MEDICATION CHANGE. A TECHNICAL SERVICE (T/S) CONSULTANT REVIEWED THE DATA FROM THE HOME MONITOR, NOTING A GRADUAL INCREASE OF OUT OF RANGE SHOCK IMPEDANCE SINCE (B)(6) 2020 OF 104 OHMS TO 127 OHMS. T/S RECOMMENDED LEAD INTEGRITY TESTING , BUT ADVISED MAY BE DUE TO PATIENT CONDITION. THE DEVICE REMAINS IMPLANTED. NO ADVERSE PATIENT EFFECTS WERE REPORTED.
Patient problems: No Known Impact Or Consequence To Patient
MAUDE report 11104633 ↗InjuryDec 18, 2020Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
IT WAS REPORTED THAT THIS IMPLANTABLE LEAD WAS PART OF A SYSTEM REVISION DUE TO INFECTION. THERE WERE NO ADDITIONAL ADVERSE PATIENT EFFECTS REPORTED. THE IMPLANTABLE LEAD WAS EXPLANTED.
Patient problems: No Code Available; Unspecified Infection
MAUDE report 11040322 ↗MalfunctionJul 6, 2020High impedance; High impedance
IT WAS REPORTED THAT THIS RIGHT VENTRICULAR (RV) LEAD HAD A GRADUAL RISE IN SHOCK IMPEDANCE, AND WERE NOW OUT OF RANGE GREATER THAN 125 OHMS. THE PLAN APPEARED TO BE TO CONTINUE TO MONITOR AT THIS TIME, AND APPEARED THAT THEY WOULD CONSIDER INCREASING THE ALERT LIMIT TO 150 OHMS. THE LEAD REMAINS IN-SERVICE. NO ADVERSE PATIENT EFFECTS WERE REPORTED.
Patient problems: No Known Impact Or Consequence To Patient
MAUDE report 10237012 ↗InjuryApr 30, 2020Signal Artifact/Noise; Failure to Capture; Fracture; Over-Sensing; Inappropriate/Inadequate Shock/Stimulation; Failure to Read Input Signal; Low impedance; Signal Artifact/Noise; Failure to Capture; Fracture; Over-Sensing; Inappropriate/Inadequate Shock/Stimulation; Failure to Read Input Signal; Low impedance
IT WAS REPORTED THAT THIS IMPLANTABLE DEFIBRILLATION LEAD EXHIBITED OVERSENSED NOISE RESULTING IN INAPPROPRIATE ANTI-TACHYCARDIA PACING (ATP) AND INAPPROPRIATE SHOCKS. IT WAS ALSO NOTED THAT THE IMPEDANCE AND SENSING MEASUREMENTS HAD DECREASED. THERE WAS A CONCERN THE LEAD HAD FRACTURED. TACHY THERAPY WAS PROGRAMMED OFF AND THE PATIENT WAS PLACED ON AN EXTERNAL DEFIBRILLATOR PRIOR TO A REVISION PROCEDURE. SUBSEQUENTLY, THE LEAD WAS EXPLANTED AND SUCCESSFULLY REPLACED. NO ADDITIONAL ADVERSE PATIENT EFFECTS WERE REPORTED.
Patient problems: No Known Impact Or Consequence To Patient
MAUDE report 10013526 ↗InjuryJan 21, 2020High impedance; Device Sensing Problem; High Capture Threshold; High impedance; Device Sensing Problem; High Capture Threshold
IT WAS REPORTED THAT THIS RIGHT VENTRICULAR (RV) LEAD EXHIBITED HIGH THRESHOLD MEASUREMENTS, NOISE AND VARIABILITY IN PACING IMPEDANCE MEASUREMENTS. THE LEAD WAS EXPLANTED DURING A ROUTINE DEVICE REPLACEMENT PROCEDURE. NO ADVERSE PATIENT EFFECTS WERE REPORTED.
Patient problems: No Code Available
MAUDE report 9612078 ↗MalfunctionJun 19, 2019High impedance; High impedance
IT WAS REPORTED THAT THIS IMPLANTABLE CARDIOVERTER DEFIBRILLATOR (ICD) EXHIBITED A GRADUAL INCREASE IN SHOCK IMPEDANCES. ONE MEASUREMENT WAS OBSERVED TO BE HIGH AND OUT OF RANGE. BOSTON SCIENTIFIC TECHNICAL SERVICES (TS) WAS CONSULTED AND MONITORING THE SYSTEM WAS RECOMMENDED. THE PHYSICIAN AGREED WITH THE PLAN TO CONTINUE MONITORING. THE ICD AND THE RIGHT VENTRICULAR (RV) LEAD REMAINS IN SERVICE. NO ADVERSE PATIENT EFFECTS WERE REPORTED.
Patient problems: No Known Impact Or Consequence To Patient
MAUDE report 8712516 ↗InjuryMay 6, 2019High impedance; High impedance
IT WAS REPORTED THAT THIS RIGHT VENTRICULAR (RV) LEAD EXHIBITED A RISE IN SHOCK IMPEDANCE MEASUREMENTS. SURGICAL INTERVENTION WAS PERFORMED AND THE RV LEAD WAS CUT AND ABANDONED IN THE PATIENT. THE END OF THE RV LEAD WILL BE RETURNED FOR ANALYSIS. NO ADDITIONAL ADVERSE PATIENT EFFECTS WERE REPORTED.
Patient problems: No Consequences Or Impact To Patient
MAUDE report 8581428 ↗MalfunctionMay 6, 2019High impedance; High impedance
IT WAS REPORTED THAT, DURING A ROUTINE FOLLOW-UP, THIS IMPLANTABLE CARDIOVERTER DEFIBRILLATOR (ICD) EXHIBITED HIGH OUT OF RANGE SHOCK IMPEDANCES ON THE RIGHT VENTRICULAR (RV) CHANNEL. BOSTON SCIENTIFIC TECHNICAL SERVICES (TS) WAS CONSULTED AND TROUBLESHOOTING RECOMMENDATIONS WERE PROVIDED. THE RECOMMENDED TESTING WAS PERFORMED IN CLINIC. IT WAS NOTED THAT THE SHOCK IMPEDANCE REMAINED HIGH BUT NO OTHER ABNORMAL ELECTRICAL MEASUREMENTS WERE OBSERVED. THE PHYSICIAN HAS ELECTED TO CONTINUE MONITORING THE SYSTEM. THIS ICD AND THE RV LEAD REMAIN IN SERVICE. NO ADVERSE PATIENT EFFECTS WERE REPORTED.
Patient problems: No Consequences Or Impact To Patient
MAUDE report 8581391 ↗
Recalls under the same FDA submission
These recalls involve devices cleared under P910073. One submission often covers many models, so check the product and lot details in each record.
- Z-2325-2025 · Jul 24, 2025 · Open, ClassifiedENDOTAK RELIANCE G/SG, transvenous defibrillation lead, implantable cardioverter defibrillator (non-CRT); Model Nos. 0160, 0161, 0162, 0163, 0164, 0165, 0166, 0167, 0170, 0171, o18
- Z-2327-2025 · Jul 24, 2025 · Open, ClassifiedRELIANCE 4-FRONT, endocardial cardioversion/defibrillation and pace/sense lead, Permanent Defibrillator Electrodes; Model Nos. 0654, 0655, 0657, 0658, 0682, 0683, 0685, 0686, 0692,
- Z-2326-2025 · Jul 24, 2025 · Open, ClassifiedENDOTAK RELIANCE G/SG with 4-SITE Connector, transvenous defibrillation lead, Permanent Defibrillator Electrodes; Model Nos. 0282, 0283, 0285, 0286, 0292, 0293, 0295, 0296
Other Implantable cardioverter defibrillator (non-CRT) devices
- EMBLEM™ MRI S-ICD A219Boston Scientific Corporation · Implantable cardioverter defibrillator (non-CRT)2 recalls36 deaths15,404 reports
- EMBLEM™ S-ICD A209Boston Scientific Corporation · Implantable cardioverter defibrillator (non-CRT)1 recall7 deaths6,788 reports
- EMBLEM™ S-ICD 3501Boston Scientific Corporation · Implantable cardioverter defibrillator (non-CRT)7 deaths4,936 reports
- Cobalt™ XT DR MRI SureScan™ DDPA2D4Medtronic, Inc. · Implantable cardioverter defibrillator (non-CRT)3 recalls30 deaths1,603 reports
- ENDOTAK RELIANCE® G 0185Boston Scientific Corporation · Implantable cardioverter defibrillator (non-CRT)9 deaths1,632 reports
- VIGILANT™ EL ICD DR D233Boston Scientific Corporation · Implantable cardioverter defibrillator (non-CRT)9 deaths1,563 reports
- Evera MRI™ XT DR SureScan® DDMB1D4Medtronic, Inc. · Implantable cardioverter defibrillator (non-CRT)1 recall35 deaths1,426 reports
- Durata™ 7122St. Jude Medical, Inc. · Implantable cardioverter defibrillator (non-CRT)27 deaths1,377 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page